Arena's Belviq scripts spike on DTC, stepped-up field force; Sanofi inks cancer marketing pact with India's Emcure;

Arena Pharmaceuticals ($ARNA) reported a 43% rise in second-quarter sales of its obesity drug Belviq as DTC ads and a beefed-up sales force gained momentum. Report

Sanofi ($SNY) tapped India's Emcure Pharmaceuticals to market its oncology drugs Taxotere, Jevtana, Fludara and Fasturtec in that country. Report

It's official: Roche ($RHHBY) has won approval to market Avastin in Europe as a treatment for recurrent ovarian cancer resistant to platinum-based chemo. Release | Report

Pfizer's ($PFE) Enbrel scored a European nod to treat a rare inflammatory joint disorder at early stages of the disease. Report

Ashfield Healthcare recruited Wendy Wolf away from Publicis Touchpoint Solutions to be its SVP of commercial and clinical operations. Report

And Finally... A new scientific review found that aspirin could stave off bowel and stomach cancers. Report